KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Globus Medical (GMED) Current Deferred Revenue (2017 - 2026)

Globus Medical filings provide 9 years of Current Deferred Revenue readings, the most recent being $27.7 million for Q4 2025.

  • On a quarterly basis, Current Deferred Revenue fell 13.03% to $27.7 million in Q4 2025 year-over-year; TTM through Dec 2025 was $27.7 million, a 13.03% decrease, with the full-year FY2025 number at $27.7 million, down 13.03% from a year prior.
  • Current Deferred Revenue hit $27.7 million in Q4 2025 for Globus Medical, up from $18.3 million in the prior quarter.
  • In the past five years, Current Deferred Revenue ranged from a high of $31.8 million in Q4 2024 to a low of $8.7 million in Q1 2021.
  • Median Current Deferred Revenue over the past 5 years was $16.0 million (2023), compared with a mean of $16.6 million.
  • Biggest five-year swings in Current Deferred Revenue: surged 73.12% in 2024 and later decreased 13.03% in 2025.
  • Globus Medical's Current Deferred Revenue stood at $12.0 million in 2021, then increased by 17.26% to $14.1 million in 2022, then soared by 30.28% to $18.4 million in 2023, then surged by 73.12% to $31.8 million in 2024, then fell by 13.03% to $27.7 million in 2025.
  • The last three reported values for Current Deferred Revenue were $27.7 million (Q4 2025), $18.3 million (Q3 2025), and $24.0 million (Q2 2025) per Business Quant data.